Da An Gene receives approval for new HIV-1 DNA detection kit

Guangzhou Da An Gene Co., Ltd. announced it has secured a new medical device registration certificate from the National Medical Products Administration. The newly approved product is an HIV-1 DNA detection kit (PCR-fluorescent probe method).

The certificate, valid until September 4, 2030, is for an in vitro qualitative detection kit. It targets Human Immunodeficiency Virus Type 1 deoxyribonucleic acid (HIV-1 DNA) (M group only) in human whole blood samples.

The company stated that obtaining this certificate enriches its product combination and broadens the application scope of its products. However, Da An Gene cautioned investors that the product is currently in the market development stage, and market demand remains uncertain, urging them to be aware of investment risks.